No Data
Chaoju Eye Care Unit Subscribes for 240 Million Yuan of Structured Deposit Products; Shares Up 8%
Chaoju Eye Care Expands BOC Investment Portfolio
In the morning, Ocumension (02219.HK) subscribed to a structured deposit product worth 0.24 billion yuan.
Great Wall News on September 27th: Shaoju Eye (02219.HK) announced that on September 27, 2024, Shaoju Medical Technology (the company's indirectly wholly-owned subsidiary) further subscribed to a principal amount of RMB 0.24 billion Bank of China structured deposit products. The subscription is funded by the group's surplus cash instead of proceeds from global offerings.
CHAOJU EYE CARE: Interim Report 2024
Morningstar Ophthalmology (2219.HK) 2024 interim performance report review: Fundamental consumer ophthalmology shows stable growth, cost reduction and efficiency improvement help the company's development.
Event: The company released its interim performance announcement, achieving a total operating income of 0.734 billion yuan in the first half of 2024, a year-on-year growth of 6.01%; achieving a net income of 0.136 billion yuan, a year-on-year decline of 9.40%; with a gross margin of 45.76.
CHAOJU EYE CARE To Go Ex-Dividend On September 11th, 2024 With 0.1307 HKD Dividend Per Share
August 30th (Beijing Time) - $CHAOJU EYE CARE(02219.HK)$ is trading ex-dividend on September 11th, 2024.Shareholders of record on September 12th, 2024 will receive 0.1307 HKD dividend per share on
No Data
No Data